Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 2154
Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Access to Global Online Research in Agriculture (AGORA)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Molecular study on the potential therapeutic activity of novel nanocomposite on cancerous tumor bearing mice
Joint Event on 15th World Congress on Biotechnology And Biotech Industries Meet and 2nd International Conference on Enzymology and Molecular Biology
Mohammed F. EL-Shiekha
October 6 University, Egypt
Posters & Accepted Abstracts: J Biotechnol Biomater
Abstract
Nanoparticles are making significant contributions in the development of new approaches of drug delivery in cancer and can provide a platform for combined therapeutics with subsequent monitoring of response. Basic curcumin and zinc oxide (ZnO) nanocomposites modified with vitamin C and CTAB have been exerting chemo-preventative activity against cancer in mice animal model. The present results observed that nanocomposite have distinct effects on liver cell viability via killing cancer cells, while posing no effect on normal cells (hepatocytes). The marked difference in cytotoxicity between cancer cells and normal cells suggests an exciting potential for nanocomposite as novel alternatives to cancer therapy. Our molecular data showed that both mRNA and protein levels of tumor suppressor gene p53 were upregulated and induce activity of DNA fragmentation in liver cells.Biography
Mohammed F El-Shiekha has completed his PhD from the Department of Biochemistry, Faculty of Veterinary Medicine, Benha University, Egypt. He is a Faculty Member in the Department of Biochemistry and pharmacy in October 6 University, Egypt. He has published 6 papers in reputed journals.
Email: mohammmedfetoh@yahoo.com
